Pharmaceuticals News and Research

RSS

Study suggests that patients with pulmonary arterial hypertension may benefit from Thelin therapy

Encysive Pharmaceuticals today announced the presentation of data from a clinical study of Thelin(TM) (sitaxsentan) in pulmonary arterial hypertension (PAH), at the European Society of Cardiology Annual Congress in Munich.

31 Aug 2004

Kiwis reverse heart disease in diabetics

New Zealand biopharmaceutical company Protemix Corporation has announced the discovery of a treatment which appears to reverse heart disease in people suffering from diabetes and may lead to a more effective intervention in a major cause of death worldwide.

30 Aug 2004

The Australian Government response to Senate inquiry into hepatitis C and blood supply

Although the Inquiry found that decision makers had made reasonable decisions in the 80s, based on the evidence available, medically acquired hepatitis C has hurt many people.

30 Aug 2004

Vast majority of heart attacks may be predicted by nine easily measurable factors

A major Canadian-led global study has found that the vast majority of heart attacks may be predicted by nine easily measurable factors and that these factors are the same in virtually every region and ethnic group worldwide.

29 Aug 2004

U.S. FDA study shows Canadian drugs to be more expensive

If you think all drugs from Canada are cheaper than U.S. drugs, think again. In the United States, generic drugs - roughly half of all prescriptions - are often cheaper than both Canadian brand-name drugs and Canadian generic drugs, according to a study by the Food and Drug Administration.

29 Aug 2004

Cymbalta, treatment for major depression hits the market

Cymbalta, a new treatment for major depression, is now available by prescription in pharmacies across the United States, Eli Lilly and Company has announced.

26 Aug 2004

FDA reinforces use of Sustiva in first-line HIV combination therapy

Bristol-Myers Squibb has announced that Sustiva® (efavirenz) has received approval from the U.S. Food and Drug Administration to include new long-term virologic and clinical data from BMS Study 006 in its prescribing information.

26 Aug 2004

Artificial heart can keep patients awaiting heart transplant alive

The results of the nine-year study of the CardioWest Total Artificial Heart have concluded that the device prevents death in critically ill patients suffering from irreversible failure of both sides of the heart who are candidates for heart transplantation.

26 Aug 2004

Powdered form of anthrax vaccine could eliminate needle injections

Researchers have developed a powdered form of an anthrax vaccine that could potentially be inhaled through the nose and eliminate the need for needle injections.

26 Aug 2004

Phase 1 clinical trial of new anticancer drug from Human Genome Sciences

Human Genome Sciences has begun dosing patients in a Phase 1 clinical trial of HGS-TR2J, a novel agonistic human monoclonal antibody to TRAIL Receptor 2, in patients with advanced solid malignancies.

25 Aug 2004

Study emphasizes the importance of monitoring blood pressure and dyslipidemia in patient's with metabolic syndrome

Having three or more traits of the metabolic syndrome significantly increases the risk of dying from coronary heart disease, cardiovascular disease or any other cause, according to a study in Circulation: Journal of the American Heart Association.

25 Aug 2004

Compounds break bonds holding dangerous pollutants together

Everything from the manufacture of new materials to the creation of modern medications relies on chemicals known as metal-based catalysts. Catalysts pack a double punch: Even as they greatly increase the rate of chemical processes, they regenerate so they can be used again.

25 Aug 2004

The next generation of single-enantiomer catalysts

Many molecules are enantiomers: they have mirror- image versions that may have identical parts but are just as different as your left hand is from your right.

23 Aug 2004

Powerful new cancer-fighting property of Herceptin

For many patients with advanced breast cancer, the cancer drug Herceptin (trastuzumab) has offered new hope when traditional cancer drugs failed to work, shrinking tumors and sending some patients into remission.

23 Aug 2004

Researchers have produced a marathon mouse that can run twice as far as normal mice

By enhancing the function of a single protein, Howard Hughes Medical Institute researchers have produced a “marathon mouse” with altered muscle composition and enough physical endurance to run twice as far as normal mice.

23 Aug 2004

Diarrhea the leading cause of death among the developing world's children

To most people in the developed world, diarrhea is a nuisance. It means some discomfort and maybe a trip to the local pharmacy.

23 Aug 2004

Existing hepatitis drug could lead to the development of new drugs for the treatment of anthrax

Thanks to new screening tools, and some luck, researchers at the University of Chicago have discovered three unrelated compounds that inhibit the two toxins – edema factor and lethal factor -- that have made anthrax one of the most feared of potential bioterror agents.

21 Aug 2004

Pharmaceuticals News and Research

Study suggests that patients with pulmonary arterial hypertension may benefit from Thelin therapy

Kiwis reverse heart disease in diabetics

The Australian Government response to Senate inquiry into hepatitis C and blood supply

Vast majority of heart attacks may be predicted by nine easily measurable factors

U.S. FDA study shows Canadian drugs to be more expensive

Cymbalta, treatment for major depression hits the market

FDA reinforces use of Sustiva in first-line HIV combination therapy

Artificial heart can keep patients awaiting heart transplant alive

Powdered form of anthrax vaccine could eliminate needle injections

Phase 1 clinical trial of new anticancer drug from Human Genome Sciences

Study emphasizes the importance of monitoring blood pressure and dyslipidemia in patient's with metabolic syndrome

Compounds break bonds holding dangerous pollutants together

The next generation of single-enantiomer catalysts

Powerful new cancer-fighting property of Herceptin

Researchers have produced a marathon mouse that can run twice as far as normal mice

Diarrhea the leading cause of death among the developing world's children

Existing hepatitis drug could lead to the development of new drugs for the treatment of anthrax

Development of plant-derived topical medications to prevent HIV/AIDS and other STD's

Sea snail offers natural healing powers for a range of illnesses from chronic pain to diseases of the brain

Research could lead to ways to prevent arrhythmias

Drug Discovery - Second Edition eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News